The treatment of Streptomyces parvulus and Streptomyces antibioticus with acriflavine or novobiocin resulted in the loss of ability to produce actinomycin.
Numerous investigations with Streptomyces species have suggested the role of plasmids as genetic determinants of a number of phenotypic properties (e.g., fertility'"', aerial mycelium formation"", antibiotic production"'-'", antibiotic resistance""' and melanin synthesis..'..') Of particular interest is the finding that antibiotic production, e.g., methylenomycin A, may depend on the presence of a plasmids'8/. Most of the evidence for the involvement of an extrachromosomal element has been based on the loss of one or more of these properties following treatment with acriflavine, ethidium bromide or elevated temperature. In this communication we report the results of experiments with Streptomyces parvulus and Streptomyces antibioticus using dyes and novobiocin to effect a loss of actinomycin-producing ability. In addition, the isolation of recombinant prototrophic strains derived by protoplast fusion with polyethylene glycol suggest the possibility that a plasmid(s) is involved in actinomycin synthesis.
Materials and Methods
Cultures S. parvulus (ATCC 12434) and S. antibioticus strain 3720 and all strains isolated from these organisms were generally maintained on slants of GYM agar medium'".
Auxotrophic strains were cultivated on the same medium supplemented with a suitable growth requirement at a concentration of 50 ug per ml (10 fig per ml of riboflavine).
Treatment to eliminate plasmids Spores of S. parvulus or S. antibioticus from a GYM agar slant were suspended in a small volume of NZ amine medium"' and transferred to 100 ml of the same medium in a 250-m1 Erlenmeyer flask. After two days cultivation at 30°C, 1-ml aliquots were inoculated into 100 ml of NZ amine medium containing acriflavine, ethidium bromide or novobiocin. Control cultures were incubated in the same medium without addition of dye or antibiotic. Novobiocin was employed since it was shown to cure R plasmids in several bacterial species with high frequency 161; in addition, the effect of elevated tempera-ture was examined. The organism was cultivated on a reciprocating shaking incubator for 2-5 days at the appropriate temperature. The mycelium was harvested by filtration on Whatman #2 filter paper and washed with 10 % sucrose solution. Protoplasts were prepared from the mycelium with lysozyme as described previously"' in order to obtain `single cell' preparations. The protoplasts were diluted in a protoplast buffer and suitable dilutions were plated on a medium favorable for regeneration at high efficiency. The reversion medium employed was a modification of the one described by OKANISHI et al."' and consisted of sucrose (150 g), fructose (40 g), CaCl2.2H2O (3.7 g), MgCI2.6H20 (5.1 g), KH2P04 (0.05 g), L-giutamic acid •HCl (2.5 g), L-histidine (0.776 g), casamino acids (1 g), MgSO4.7H20 (0.05 g), ZnS04.7H20 (0.025 g), FeSO4.7H2O (0.025 g) and TES buffer (250 nil of 0.1 M pH 7.2) and agar (20 g ) in a total volume of I liter of deionized water. Following reversion (5 days for S. parvulus; 9 days for S. antibioticus), the colonies were randomly selected and transferred to GYM agar plugs (diam. 9.0 mm x thickness 5.0 nmm). After 5-day incubation, the agar plugs were tested for the presence or absence of antibiotic by a bioassay procedure using antibiotic medium seeded with spores of Bacillus subtilis.
Determination of actinomycin and aerial mycelium formation The plates were incubated overnight at 37°C and actinomycin-negative strains (act-) were detected by the absence of a zone of inhibition around the agar plug. The lack of ability to produce the antibiotic was subsequently confirmed by cultivation of the strains in liquid medium. Antibiotic synthesis was measured in the culture filtrate and mycelium by spectrophotometric19' and bioassay methods. Further sensitivity with respect to antibiotic synthesis was achieved by incubation of the organism with radioactive precursors followed by thin-layer chromatography and autoradiographyl".
The parental strains subjected to the same procedures (without AF, EB or novobiocin treatment) generally synthesize 500'600 tcg/ml (S. parvulus, GHF medium201) or 70' 110 tog/ml (S. antibioticus, GGG medium21').
Aerial mycelium formation was checked microscopically after cultivation of treated cells on both GYM and SYM (in which soluble starch replaced glucose) agar slants. The incidence of auxotrophic strains after treatment was determined by observing growth on GHF agar medium (minimal medium) and GHF agar medium supplemented with 0.1 % casamino acids (complete medium).
Protoplast fusion The protoplast fusion experiments that were carried out will be described in detail elsewhere. For fusion of protoplasts (2 x 109 for each auxotrophic strain), polyethylene glycol 4000 (final concentration, 42Y. w/v) was used. Fused protoplast mixtures were plated on minimal medium (GHFreversion medium) for 5' 10 days at 30°C. Prototrophic recombinants, which appeared, were then streaked for two successive passages to purify progeny.
Auxotrophic strains, used for fusion experiments, were obtained by NTG treatment according to the procedure of DELI45 et al."' Reagents Novobiocin was a gift from Dr. 0. SEBEK, Upjohn & Co., Kalamazoo, Mich.; 14C-Labeled 4-methyl-3-hydroxyanthranilic acid was kindly provided by Dr. T. TROOST of this laboratory.
Polyethylene glycol (PEG) 4000 was purchased from Sigma Chem. Co., St. Louis, Mo. Other reagents employed were from commercial sources and were analytical grade.
Results
A preliminary experiment was carried out with acriflavine (AF) and ethidium bromide (EB) to determine whether the loss of antibiotic producing ability would be observed. Ss parvulus was cultivated for 5 days in NZ amine medium containing the highest concentration of AF (5 tog/ml) or EB (5 tog/ml) permitting growth. After incubation, regeneration of protoplasts was carried out on GHF-reversion medium supplemented with 0.1 % casamino acids (see Materials and Methods) and actinomycin synthesis was assayed by the agar plug method. With S. parvulus we observed that 1.1 % (EB, 5/438) and 5.1 (AF, 26/513) of the progeny tested had lost the ability to synthesize actinomycin. By contrast, in 1145 VOL. XXXI NO. 11
THE JOURNAL OF ANTIBIOTICS the case of the untreated control, only 0.3 % (1/349) colonies tested was a non-producing strain. These findings suggested the possibility that a plasmid(s) may be involved in actinomycin biosynthesis.
A second experiment was conducted in which the organism was successively transferred in NZ amine medium containing increasing concentrations of EB or AF as shown in Table 1 . Since AF and EB are known to restrict plasmid replication during cell growth, it was considered likely that repeated cultivation would provide a more effective means for loss of a plasmid(s). To establish that this treatment did not result in a significant deletion of chromosomal DNA, the incidence of auxotrophic progeny requiring components of casamino acids was also determined. The effect of elevated temperature and novobiocin for obtaining antibiotic-negative strains are also presented in Table 1 . The incidence of S. parvulaas progeny lacking the ability to synthesize actinomycin was found to be relatively high with AF (15 %) and novobiocin (13.5 %), whereas EB (2.8 %) and high temperature (0.7 %) were not nearly as effective treatments. In contrast, with S. antibioticus, acriflavine proved to be far more effective than novobiocin for obtaining act-strains. In the investigation with Se parvulus we observed that loss of ability to form aerial mycelium and the incidence of auxotrophic progeny were both low relative to the loss of antibiotic producing ability. The data shown in Table I Cosynthesis studies between act-strains using Table 1 . Effect of various treatments on actinomycin production, aerial mycelium formation and auxotrophy. Table 2 shows the frequency of recombination between protoplasts prepared from various auxotrophic strains of S. parvuhts induced by polyethylene glycol treatment. Strain #44-2 (cys , act-) was derived from strain #44 (cys-) by acriflavine treatment. NTG treatment was used to obtain all the nutritionally-dependent strains isolated. In order to determine the back mutation frequency, two hundred progeny from strain #44-2 (cys-, act) were selected at random and tested by the agar plug method; none of the progeny were found to produce actinomycin. Examination of Table 2 reveals that high recombination frequencies to prototrophy (9.6 -15 %)
were obtained by the protoplast fusion method.
As will be described elsewhere, the colonies seen on minimal medium were true recombinants and not heterokaryons or diploids. It was shown that when PEG was omitted, recombinants were not observed even when high densities of protoplast mixtures were plated on reversion medium.
The recombinants, after purification by streaking on GHF-minimal medium to isolate single colonies, were examined for their ability to synthesize actinomycin by the agar plug method using GYM agar medium and representative colonies were also checked in GHF liquid medium. The results, shown in Table 3 , reveal that there is a high frequency (84"95%) of the actinomycin synthesizing character among the prototrophic recombinants examined. Protoplast fusion experiments were also carried out between auxotrophic, non-producing strains #44-2 (cys-, act-) and #303-1 (ura-, lys-, act) or #330-2 (rib-, meth-, act-). While prototrophic recombinants were obtained efficiently, no actinomycin-producing recombinants were ever detected. Although a genetic map for S. parvulus has not been determined as yet, it is reasonable to assume from previously published studies2" with S. coelicolor and other Streptomyces that the auxotrophic mutations induced are randomly distributed on the chromosome and that, at least, some of the genetic determinants involved with actinomycin synthesis 1 The nutritional requirement of auxotrophic strains was added at a concentration of 50 tag/ml except for riboflavine (10 tag/ml). 2 Nutritional requirements are designated cysteine (cys ), tryptophan (try), threorine (threo-), uracil (ura-), riboflavine (rib-) and tyrosine (t} r ); act-indicates inability to produce aetinomycin. are not linked with the prototrophic markers examined (try, threo, ura, rib and tyr). The results of a more detailed genetic analysis for the determinants concerned with actinomycin production will be published elsewhere.
Discussion
The results described herein strongly support the view that a plasmid(s) plays a role in actinomycin formation.
Loss of antibiotic-producing ability was seen when several `curing' agents such as AF, EB and novobiocin were used. The act-phenotypic character was established by bioassays, a spectrophotometric procedure and radiolabeling experiments. Moreover, the loss appeared to be a stable property of the progeny isolated. By comparison, the loss of ability to form aerial mycelium as well as the incidence of nutritional dependency occurred at much lower frequencies in these experiments. Additional evidence for the role of a plasmid(s) in actinomycin synthesis was provided by the protoplast fusion experiments and cosynthesis studies.
Prototrophic recombinants obtained from fusion between actinomycin-negative strains were never found to be act-, whereas similar experiments involving different auxotrophic act genotypes with an act auxotrophic strain always showed a high frequency of the act genotype in the prototrophic recombinants.
Although transfer of certain plasmids has not been shown to occur by conjugation''24', it may be possible to mediate the transfer by application of protoplast fusion techniques. This procedure provides a new, efficient method for genetic exchange and may have wide application for examining interstrain and interspecific comb inations25'.
